Filing Details
- Accession Number:
- 0001415889-24-027597
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-25 08:33:23
- Reporting Period:
- 2024-11-21
- Accepted Time:
- 2024-11-25 08:33:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1472012 | Immunome Inc. | IMNM | Pharmaceutical Preparations (2834) | 770694340 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2026600 | Philip Tsai | C/O Immunome, Inc. 18702 N. Creek Parkway, Suite 100 Bothell WA 98011 | Chief Technology Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-21 | 21,000 | $9.43 | 21,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchase price for the reported transactions was $9.43. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, the Reporting Person will provide the full information regarding the securities purchased.
Billionaire Hedge Funds
